Trials / Completed
CompletedNCT04690868
A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131
A Randomized, Open Label, Multi Dose, Cross Over Design Clinical Study to Evaluate the Pharmacokinetic Pharmacodynamic Characteristics and Safety of AD-213-A and AD-2131 After Oral Administration in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-A to AD-2131 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-213-A | 1 tablet administered before the breakfast during 5 days |
| DRUG | AD-2131 | 1 tablet administered before the breakfast during 5 days |
Timeline
- Start date
- 2021-10-15
- Primary completion
- 2021-12-11
- Completion
- 2021-12-21
- First posted
- 2020-12-31
- Last updated
- 2022-04-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04690868. Inclusion in this directory is not an endorsement.